Cureskin, the revolutionary platform connecting users with skincare experts, has just raised a whopping $20 million in a Series B funding round. HealthQuad, a highly respected healthcare-focused venture capital firm, led the round.
The company maintained its excellence by continuing to receive backing from existing investors like Khosla Ventures, JSW Ventures, and Sharrp Ventures. Cureskin has raised an astounding $26 million so far.
Breakthrough technology at work
Since 2017, Guna Kakulapati, Ramakrishna Rajanna, and Charu Sharma have led advanced skincare innovation at Cureskin. Moreover, the company has examined over 10 million skin pixels and extracted over 2,000 facial features using cutting-edge photo-analysis technology. Identifying various skin conditions and their severity with this innovative method has changed how people look at and address skincare concerns.
However, with this significant funding infusion, the company is prepared to enhance its AI capabilities and expand its portfolio of solutions. What’s more? The company will use these funds to advance modern technology as part of its overall strategy. This will provide users with access to the most cutting-edge skincare innovations like never before.
The CEO of Cureskin, Guna Kakulapati, expressed enthusiasm about the investment and emphasised how it fits with the company’s goal of meeting the growing demand for easily accessible skincare expertise. He underlined the company’s commitment to employing AI to boost service offerings, accelerate expansion, and deliver quality care to a broader audience.
Its reach and impact
Cureskin’s impact exceeds demographic boundaries, as proven by the fact that its application has attended to more than 15 lakh clients. The platform helps with acne, hyperpigmentation, post-acne problems, and hair loss. Notably, more than 80 per cent of the company’s customers derive from Tier-II and Tier-III regions. This serves as an indication of the brand’s accessibility and efficacy.
Industry endorsement and growth projections
Dr Pinak Shrikhande, Managing Director of HealthQuad, praised Cureskin’s digital-first approach and AI-powered diagnostics. She highlighted its role in democratising dermatological care. Industry projections support this sentiment, indicating robust growth in the Indian beauty and personal care market. Experts estimate the market to reach $30 billion by 2027.
Strategic investment
Cureskin’s cutting-edge technology-driven skincare products have revolutionised dermatological treatment, and their current investment round underlines this. The strategic investment will allow the company to grow their research and development and reach more people, ensuring that everyone can benefit from their unique skincare products.
Its AI-powered skin analysis technology gives each user customised skincare recommendations based on their skin type and problems. This ensures consumers get the best solutions for their needs, improving results and customer satisfaction.